Metabolically unhealthy obesity, sarcopenia and their interactions in obesity pathophysiology and therapeutics: Room for improvement in pharmacotherapy

被引：3
作者：
Katsarou, Angeliki [1 ]
Kouvari, Matina [1 ,5 ]
Hill, Michael A. [3 ,4 ]
Mantzoros, Christos S. [1 ,2 ]
机构：
[1] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA USA
[2] Boston VA Healthcare Syst, Dept Med, Boston, MA USA
[3] Univ Missouri, Dalton Cardiovasc Res Ctr, Columbia, MO USA
[4] Univ Missouri, Dept Med Pharmacol & Physiol, Columbia, MO USA
[5] Beth Israel Deaconess Med Ctr, 330 Brookline Ave,SL418, Boston, MA 02215 USA
来源：
METABOLISM-CLINICAL AND EXPERIMENTAL | 2023年 / 149卷
关键词：
Obesity; Eight loss; Sarcopenia; Sarcopenic obesity; Type; 2; diabetes; Treatment; HEALTHY OBESITY; NORMAL-WEIGHT; RISK; MYOSTATIN; CRITERIA;
D O I：
10.1016/j.metabol.2023.155714
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：4
相关论文
共 55 条
  • [1] Circulating follistatin displays a day-night rhythm and is associated with muscle mass and circulating leptin levels in healthy, young humans
    Anastasilakis, Athanasios D.
    Polyzos, Stergios A.
    Skouvaklidou, Elpida C.
    Kynigopoulos, Georgios
    Saridakis, Zacharias G.
    Apostolou, Aggeliki
    Triantafyllou, Georgios A.
    Karagiozoglou-Lampoudi, Thomai
    Mantzoros, Christos S.
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 2016, 65 (10): : 1459 - 1465
  • [2] Novel Noninvasive Approaches to the Treatment of Obesity: From Pharmacotherapy to Gene Therapy
    Angelidi, Angeliki M.
    Belanger, Matthew J.
    Kokkinos, Alexander
    Koliaki, Chrysi C.
    Mantzoros, Christos S.
    [J]. ENDOCRINE REVIEWS, 2021, 43 (03) : 507 - 557
  • [3] IFSO Worldwide Survey 2016: Primary, Endoluminal, and Revisional Procedures
    Angrisani, Luigi
    Santonicola, A.
    Iovino, P.
    Vitiello, A.
    Higa, K.
    Himpens, J.
    Buchwald, H.
    Scopinaro, N.
    [J]. OBESITY SURGERY, 2018, 28 (12) : 3783 - 3794
  • [4] [Anonymous], 2020, Constitution of the World Health Organization
  • [5] [Anonymous], 1988, Am J Clin Nutr, V50, P1121
  • [6] Diabetes and Cardiovascular Disease Outcomes in the Metabolically Healthy Obese Phenotype
    Appleton, Sarah L.
    Seaborn, Christopher J.
    Visvanathan, Renuka
    Hill, Catherine L.
    Gill, Tiffany K.
    Taylor, Anne W.
    Adams, Robert J.
    [J]. DIABETES CARE, 2013, 36 (08) : 2388 - 2394
  • [7] Atlas SJ, 2022, Final evidence report
  • [8] Addressing Obesity in Aging Patients
    Batsis, John A.
    Zagaria, Alexandra B.
    [J]. MEDICAL CLINICS OF NORTH AMERICA, 2018, 102 (01) : 65 - +
  • [9] Health Outcomes of Sarcopenia: A Systematic Review and Meta-Analysis
    Beaudart, Charlotte
    Zaaria, Myriam
    Pasleau, Francoise
    Reginster, Jean-Yves
    Bruyere, Olivier
    [J]. PLOS ONE, 2017, 12 (01):
  • [10] Effects of once-weekly semaglutide on appetite, energy intake, control of eating, food preference and body weight in subjects with obesity
    Blundell, John
    Finlayson, Graham
    Axelsen, Mads
    Flint, Anne
    Gibbons, Catherine
    Kvist, Trine
    Hjerpsted, Julie B.
    [J]. DIABETES OBESITY & METABOLISM, 2017, 19 (09) : 1242 - 1251
123456